Cargando…

Integrated clinical, whole-genome, and transcriptome analysis of multisampled lethal metastatic prostate cancer

We report the first combined analysis of whole-genome sequence, detailed clinical history, and transcriptome sequence of multiple prostate cancer metastases in a single patient (A21). Whole-genome and transcriptome sequence was obtained from nine anatomically separate metastases, and targeted DNA se...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bova, G. Steven, Kallio, Heini M.L., Annala, Matti, Kivinummi, Kati, Högnäs, Gunilla, Häyrynen, Sergei, Rantapero, Tommi, Kivinen, Virpi, Isaacs, William B., Tolonen, Teemu, Nykter, Matti, Visakorpi, Tapio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cold Spring Harbor Laboratory Press 2016
Materias:	Research Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4853517/ https://www.ncbi.nlm.nih.gov/pubmed/27148588 http://dx.doi.org/10.1101/mcs.a000752

Ejemplares similares

Constitutively active androgen receptor splice variants AR-V3, AR-V7 and AR-V9 are co-expressed in castration-resistant prostate cancer metastases
por: Kallio, Heini M. L., et al.
Publicado: (2018)

The expression of AURKA is androgen regulated in castration-resistant prostate cancer
por: Kivinummi, Kati, et al.
Publicado: (2017)

DOT1L-HES6 fusion drives androgen independent growth in prostate cancer
por: Annala, Matti, et al.
Publicado: (2014)

Cancer origin tracing and timing in two high-risk prostate cancers using multisample whole genome analysis: prospects for personalized medicine
por: Nurminen, Anssi, et al.
Publicado: (2023)

The Evolutionary History of Lethal Metastatic Prostate Cancer
por: Gundem, Gunes, et al.
Publicado: (2015)

Microseminoprotein-Beta Expression in Different Stages of Prostate Cancer
por: Sjöblom, Liisa, et al.
Publicado: (2016)

Integrative proteomics in prostate cancer uncovers robustness against genomic and transcriptomic aberrations during disease progression
por: Latonen, Leena, et al.
Publicado: (2018)

Inherited DNA Repair Gene Mutations in Men with Lethal Prostate Cancer
por: Rantapero, Tommi, et al.
Publicado: (2020)

Proteomics of prostate cancer – revealing how cancer cells master their messy genomes
por: Latonen, Leena, et al.
Publicado: (2018)

Recurrent SKIL-activating rearrangements in ETS-negative prostate cancer
por: Annala, Matti, et al.
Publicado: (2015)

Epigenetically altered miR-193b targets cyclin D1 in prostate cancer
por: Kaukoniemi, Kirsi M, et al.
Publicado: (2015)

Combined Longitudinal Clinical and Autopsy Phenomic Assessment in Lethal Metastatic Prostate Cancer: Recommendations for Advancing Precision Medicine
por: Jasu, Juho, et al.
Publicado: (2021)

Segmentum: a tool for copy number analysis of cancer genomes
por: Afyounian, Ebrahim, et al.
Publicado: (2017)

Clinical association analysis of ependymomas and pilocytic astrocytomas reveals elevated FGFR3 and FGFR1 expression in aggressive ependymomas
por: Lehtinen, Birgitta, et al.
Publicado: (2017)

Strong FGFR3 staining is a marker for FGFR3 fusions in diffuse gliomas
por: Granberg, Kirsi J, et al.
Publicado: (2017)

Identification of long noncoding RNAs with aberrant expression in prostate cancer metastases
por: Sattari, Mina, et al.
Publicado: (2023)

Feature-based analysis of mouse prostatic intraepithelial neoplasia in histological tissue sections
por: Ruusuvuori, Pekka, et al.
Publicado: (2016)

A Linear Model for Transcription Factor Binding Affinity Prediction in Protein Binding Microarrays
por: Annala, Matti, et al.
Publicado: (2011)

Whole-exome sequencing identifies germline mutation in TP53 and ATRX in a child with genomically aberrant AT/RT and her mother with anaplastic astrocytoma
por: Nordfors, Kristiina, et al.
Publicado: (2018)

Erratum: Whole-exome sequencing identifies germline mutation in TP53 and ATRX in a child with genomically aberrant AT/RT and her mother with anaplastic astrocytoma
por: Nordfors, Kristiina, et al.
Publicado: (2018)

Comparative analysis of tissue reconstruction algorithms for 3D histology
por: Kartasalo, Kimmo, et al.
Publicado: (2018)

Analysis of spatial heterogeneity in normal epithelium and preneoplastic alterations in mouse prostate tumor models
por: Valkonen, Mira, et al.
Publicado: (2017)

Improved Triacylglycerol Production in Acinetobacter baylyi ADP1 by Metabolic Engineering
por: Santala, Suvi, et al.
Publicado: (2011)

Ageing-associated changes in the human DNA methylome: genomic locations and effects on gene expression
por: Marttila, Saara, et al.
Publicado: (2015)

Spatial analysis of histology in 3D: quantification and visualization of organ and tumor level tissue environment
por: Ruusuvuori, Pekka, et al.
Publicado: (2022)

CIP2A is a candidate therapeutic target in clinically challenging prostate cancer cell populations
por: Khanna, Anchit, et al.
Publicado: (2015)

Nonmalignant AR-positive prostate epithelial cells and cancer cells respond differently to androgen
por: Kukkonen, Konsta, et al.
Publicado: (2022)

Extensive reprogramming of the nascent transcriptome during iPSC to hepatocyte differentiation
por: Viiri, Leena E., et al.
Publicado: (2019)

Nonparametric maximum likelihood estimation for the multisample Wicksell corpuscle problem
por: Chan, Kwun Chuen Gary, et al.
Publicado: (2016)

TransMeta simultaneously assembles multisample RNA-seq reads
por: Yu, Ting, et al.
Publicado: (2022)

On-Site Multisample Determination of Chlorogenic Acid in Green Coffee by Chemiluminiscent Imaging
por: Mallorca-Cebria, Sergi, et al.
Publicado: (2023)

Overall and worst gleason scores are equally good predictors of prostate cancer progression
por: Tolonen, Teemu T, et al.
Publicado: (2011)

Construction of therapeutically relevant human prostate epithelial fate map by utilising miRNA and mRNA microarray expression data
por: Rane, Jayant K, et al.
Publicado: (2015)

ATARiS: Computational quantification of gene suppression phenotypes from multisample RNAi screens
por: Shao, Diane D., et al.
Publicado: (2013)

Expression of the miR-200 family in tumor tissue, plasma and urine of epithelial ovarian cancer patients in comparison to benign counterparts
por: Savolainen, Kalle, et al.
Publicado: (2020)

Leukemia Prediction Using Sparse Logistic Regression
por: Manninen, Tapio, et al.
Publicado: (2013)

Frequent mutation of the FOXA1 untranslated region in prostate cancer
por: Annala, Matti, et al.
Publicado: (2018)

PTPRD and CNTNAP2 as markers of tumor aggressiveness in oligodendrogliomas
por: Rautajoki, Kirsi J., et al.
Publicado: (2022)

Copy Number Analysis Indicates Monoclonal Origin of Lethal Metastatic Prostate Cancer
por: Liu, Wennuan, et al.
Publicado: (2009)

A Multisampling Reporter System for Monitoring MicroRNA Activity in the Same Population of Cells
por: Huang, Pei-Chen, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_q0imok8vcgh2loie6emr0fkq4r